Login / Signup

Development of primary osteoarthritis during aging in genetically diverse UM-HET3 mice.

Sher Bahadur PoudelRyan R RuffGozde YildirimRichard A MillerDavid E HarrisonRandy StrongThorsten KirschShoshana Yakar
Published in: bioRxiv : the preprint server for biology (2023)
This study investigated the prevalence and progression of primary osteoarthritis (OA) in aged UM-HET3 mice. Using the Osteoarthritis Research Society International (OARSI) scoring system, we assessed articular cartilage (AC) integrity in 182 knee joints of 22-25 months old mice. We found a high prevalence of primary OA in both sexes of mice, with 85% of male and 90% of female mice showing varying degrees of OA during aging. Significant positive correlations were found between AC scores and synovitis, osteophyte formation, and ectopic chondrogenesis in control mice of both sexes. Significant direct correlations were found between AC scores and inflammatory markers in chondrocytes, including matrix metalloproteinase-13 (MMP-13), inducible nitric oxide synthase (iNOS), and the NLR family pyrin domain containing-3 (NLRP3) inflammasome in both sexes, indicating a link between OA severity and inflammation. Additionally, markers of cell cycle arrest, such as p16 and β-galactosidase, also correlated with AC scores. Using micro-CT, we examined the correlations between subchondral bone (SCB) morphology traits and AC scores. In male mice, no significant correlations were found between SCB volume and AC scores, while in female control mice, significant correlations were observed between AC scores and SCB volume in the femur. Finally, we explored the effects of methylene blue (MB) and mitoquinone (MitoQ), two agents that affect mitochondrial function, on the prevalence and progression of OA during aging. Notably, MB and MitoQ treatments influenced the disease's progression in a sex-specific manner. In males, MB treatment exacerbated OA, while MitoQ showed mixed results. In contrast, both treatments in females increased the proportion of mice without OA, suggesting a potential slowing of OA progression. In conclusion, our study provides comprehensive insights into the prevalence and progression of primary OA in aged UM-HET3 mice, highlighting the sex-specific effects of MB and MitoQ treatments. The correlations between AC scores and various pathological factors underscore the multifaceted nature of OA and its association with inflammation and subchondral bone changes.
Keyphrases